 Antibodies
"Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
| Descriptor ID |
D000906
|
| MeSH Number(s) |
D12.776.124.486.485.114 D12.776.124.790.651.114 D12.776.377.715.548.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Antibodies".
- Antibodies
- Antibodies, Anti-Idiotypic
- Antibodies, Archaeal
- Antibodies, Bacterial
- Antibodies, Bispecific
- Antibodies, Blocking
- Antibodies, Catalytic
- Antibodies, Fungal
- Antibodies, Helminth
- Antibodies, Heterophile
- Antibodies, Immobilized
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antibodies, Neutralizing
- Antibodies, Phospho-Specific
- Antibodies, Protozoan
- Antibodies, Viral
- Antigen-Antibody Complex
- Antitoxins
- Autoantibodies
- Immune Sera
- Immunoconjugates
- Immunoglobulin Allotypes
- Immunoglobulin Isotypes
- Immunoglobulins, Intravenous
- Immunoglobulins, Thyroid-Stimulating
- Insulin Antibodies
- Isoantibodies
- Oligoclonal Bands
- Opsonin Proteins
- Plantibodies
- Precipitins
- Reagins
This graph shows the total number of publications written about "Antibodies" by people in this website by year, and whether "Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 5 | 0 | 5 | | 1981 | 1 | 2 | 3 | | 1982 | 0 | 2 | 2 | | 1983 | 1 | 0 | 1 | | 1984 | 1 | 4 | 5 | | 1985 | 3 | 0 | 3 | | 1986 | 1 | 2 | 3 | | 1987 | 0 | 2 | 2 | | 1988 | 3 | 0 | 3 | | 1989 | 0 | 1 | 1 | | 1990 | 4 | 4 | 8 | | 1991 | 4 | 3 | 7 | | 1992 | 1 | 2 | 3 | | 1993 | 1 | 1 | 2 | | 1994 | 0 | 3 | 3 | | 1995 | 0 | 7 | 7 | | 1996 | 1 | 2 | 3 | | 1997 | 1 | 3 | 4 | | 1998 | 3 | 6 | 9 | | 1999 | 0 | 5 | 5 | | 2000 | 0 | 7 | 7 | | 2001 | 1 | 6 | 7 | | 2002 | 0 | 4 | 4 | | 2003 | 2 | 5 | 7 | | 2004 | 2 | 3 | 5 | | 2005 | 1 | 4 | 5 | | 2006 | 1 | 4 | 5 | | 2007 | 6 | 11 | 17 | | 2008 | 4 | 7 | 11 | | 2009 | 5 | 6 | 11 | | 2010 | 3 | 8 | 11 | | 2011 | 6 | 2 | 8 | | 2012 | 5 | 3 | 8 | | 2013 | 4 | 8 | 12 | | 2014 | 4 | 7 | 11 | | 2015 | 7 | 2 | 9 | | 2016 | 1 | 3 | 4 | | 2017 | 3 | 4 | 7 | | 2018 | 6 | 3 | 9 | | 2019 | 4 | 3 | 7 | | 2020 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies" by people in Profiles.
-
Sharma P, Marada VVVR, Cai Q, Kizerwetter M, He Y, Wolf SP, Schreiber K, Clausen H, Schreiber H, Kranz DM. Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides. Proc Natl Acad Sci U S A. 2020 06 30; 117(26):15148-15159.
-
Möller L, Regnier G, Labro AJ, Blunck R, Snyders DJ. Determining the correct stoichiometry of Kv2.1/Kv6.4 heterotetramers, functional in multiple stoichiometrical configurations. Proc Natl Acad Sci U S A. 2020 04 28; 117(17):9365-9376.
-
Mukherjee S, Erramilli SK, Ammirati M, Alvarez FJD, Fennell KF, Purdy MD, Skrobek BM, Radziwon K, Coukos J, Kang Y, Dutka P, Gao X, Qiu X, Yeager M, Eric Xu H, Han S, Kossiakoff AA. Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins. Nat Commun. 2020 03 27; 11(1):1598.
-
Katsumata K, Ishihara J, Fukunaga K, Ishihara A, Yuba E, Budina E, Hubbell JA. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-a antibody in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2019 12 23; 21(1):298.
-
Katsumata K, Ishihara J, Mansurov A, Ishihara A, Raczy MM, Yuba E, Hubbell JA. Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Sci Adv. 2019 11; 5(11):eaay1971.
-
Park S, Reyer MA, McLean EL, Liu W, Fei J. An Improved Method for Bacterial Immunofluorescence Staining To Eliminate Antibody Exclusion from the Fixed Nucleoid. Biochemistry. 2019 11 12; 58(45):4457-4465.
-
Dutka P, Mukherjee S, Gao X, Kang Y, de Waal PW, Wang L, Zhuang Y, Melcher K, Zhang C, Xu HE, Kossiakoff AA. Development of "Plug and Play" Fiducial Marks for Structural Studies of GPCR Signaling Complexes by Single-Particle Cryo-EM. Structure. 2019 12 03; 27(12):1862-1874.e7.
-
Green PHR, Guandalini S. When Is Celiac Disease Celiac Disease? Gastroenterology. 2019 08; 157(2):293-294.
-
Missiakas D. Staphylococcus aureus TarP: A Brick in the Wall or Rosetta Stone? . 2019 02 13; 25(2):182-183.
-
Kinman AWL, Pompano RR. Optimization of Enzymatic Antibody Fragmentation for Yield, Efficiency, and Binding Affinity. Bioconjug Chem. 2019 03 20; 30(3):800-807.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|